Michael Nguyen Trinh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael Nguyen Trinh has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Feiran Lu
Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390
5 shared publications - Joseph L. Goldstein
Chair, Lasker Awards Jury, Lasker Foundation
4 shared publications - Michael S. Brown
Department of Molecular Genetics, University of Texas Southwestern Medical Center
4 shared publications Gonçalo Vale
Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390
2 shared publicationsJeffrey G. McDonald
Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390
2 shared publicationsJoachim Seemann
Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States
2 shared publications
Latest Publications
- Open Access
Exome wide association study for blood lipids in 1,158,017 individuals from diverse populations
Rare coding alleles play crucial roles in the molecular diagnosis of genetic diseases. However, the systemic identification of these alleles has been challenging due to their scarcity in the general population. Here, we discovered and characterized rare coding alleles contributing to genetic dyslipidemia, a principal risk for coronary artery disease, among over a million individuals combining three large contemporary genetic datasets (the Million Veteran Program, n = 634,535, UK Biobank, n = 431,178, and the All of Us Research Program, n = 92,304) totaling 1,158,017 multi-ancestral individuals. Unlike previous rare variant studies in lipids, this study included 238,243 individuals (20.6%) from non-European-like populations. Testing 2,997,401 rare coding variants from diverse backgrounds, we identified 800 exome-wide significant associations across 209 genes including 176 predicted loss of function and 624 missense variants. Among these exome-wide associations, 130 associations were driven by non-European-like populations. Associated alleles are highly enriched in functional variant classes, showed significant additive and recessive associations, exhibited similar effects across populations, and resolved pathogenicity for variants enriched in African or South-Asian populations. Furthermore, we identified 5 lipid-related genes associated with coronary artery disease (RORC, CFAP65, GTF2E2, PLCB3, and ZNF117) . Among them, RORC is a potentially novel therapeutic target through the down regulation of LDLC by its silencing. This study provides resources and insights for understanding causal mechanisms, quantifying the expressivity of rare coding alleles, and identifying novel drug targets across diverse populations.
Open AccessExome wide association study for blood lipids in 1,158,017 individuals from diverse populations
Rare coding alleles play crucial roles in the molecular diagnosis of genetic diseases. However, the systemic identification of these alleles has been challenging due to their scarcity in the general population. Here, we discovered and characterized rare coding alleles contributing to genetic dyslipidemia, a principal risk for coronary artery disease, among over a million individuals combining three large contemporary genetic datasets (the Million Veteran Program, n = 634,535, UK Biobank, n = 431,178, and the All of Us Research Program, n = 92,304) totaling 1,158,017 multi-ancestral individuals. Unlike previous rare variant studies in lipids, this study included 238,243 individuals (20.6%) from non-European-like populations. Testing 2,997,401 rare coding variants from diverse backgrounds, we identified 800 exome-wide significant associations across 209 genes including 176 predicted loss of function and 624 missense variants. Among these exome-wide associations, 130 associations were driven by non-European-like populations. Associated alleles are highly enriched in functional variant classes, showed significant additive and recessive associations, exhibited similar effects across populations, and resolved pathogenicity for variants enriched in African or South-Asian populations. Furthermore, we identified 5 lipid-related genes associated with coronary artery disease (RORC, CFAP65, GTF2E2, PLCB3, and ZNF117) . Among them, RORC is a potentially novel therapeutic target through the down regulation of LDLC by its silencing. This study provides resources and insights for understanding causal mechanisms, quantifying the expressivity of rare coding alleles, and identifying novel drug targets across diverse populations.
- Open Access
- 25 December 2023
- Published by Elsevier in JACC: Advances
- Vol. 3 (2)
Lipoprotein(a) Concentrations Are Independent of Polygenic Score for Coronary Artery Disease
- 25 December 2023
- Published by Elsevier in JACC: Advances
- Vol. 3 (2)
Open AccessLipoprotein(a) Concentrations Are Independent of Polygenic Score for Coronary Artery Disease
- Open Access
- 6 January 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (2)
Interplay between Asters/GRAMD1s and phosphatidylserine in intermembrane transport of LDL cholesterol
Significance: Cholesterol constitutes 50% of lipids in the plasma membrane (PM) of animal cells. Sensors in the endoplasmic reticulum (ER) maintain this level by adjusting cholesterol uptake, synthesis, and storage. Uptake is mediated by LDL receptors, which deliver cholesterol-carrying LDL to lysosomes from which cholesterol moves to the PM and then to the ER. We report PM-to-ER transport of LDL cholesterol requires cholesterol-binding Aster proteins anchored to the ER and phosphatidylserine embedded in the PM. Asters are known to bind phosphatidylserine, and this accounts for part of the phosphatidylserine requirement. However, the current data suggest an additional requirement for phosphatidylserine independent of Asters. These data advance our knowledge of PM cholesterol homeostasis, a control mechanism essential for cell growth and survival.
- 6 January 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (2)
Open AccessInterplay between Asters/GRAMD1s and phosphatidylserine in intermembrane transport of LDL cholesterol
Significance: Cholesterol constitutes 50% of lipids in the plasma membrane (PM) of animal cells. Sensors in the endoplasmic reticulum (ER) maintain this level by adjusting cholesterol uptake, synthesis, and storage. Uptake is mediated by LDL receptors, which deliver cholesterol-carrying LDL to lysosomes from which cholesterol moves to the PM and then to the ER. We report PM-to-ER transport of LDL cholesterol requires cholesterol-binding Aster proteins anchored to the ER and phosphatidylserine embedded in the PM. Asters are known to bind phosphatidylserine, and this accounts for part of the phosphatidylserine requirement. However, the current data suggest an additional requirement for phosphatidylserine independent of Asters. These data advance our knowledge of PM cholesterol homeostasis, a control mechanism essential for cell growth and survival.
- Open Access
- 20 July 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (31) , 18521-18529
Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine
Significance: Feedback control of cholesterol metabolism is essential for cell viability and prevention of heart attacks. Cells acquire cholesterol from receptor-mediated uptake of low-density lipoprotein, which delivers cholesterol to lysosomes. To exert feedback control, cholesterol must reach the endoplasmic reticulum (ER). Here we use a CRISPR screen to show that lysosome-derived cholesterol moves first to the plasma membrane and then to the ER. The last movement requires an enzyme that produces phosphatidylserine. This demonstrates that transmembrane movement of one lipid (cholesterol) requires another lipid (phosphatidylserine). Our results explain how one organelle (ER) monitors the cholesterol content of another organelle (plasma membrane), thereby maintaining membrane integrity and ensuring cell survival.
- 20 July 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (31) , 18521-18529
Open AccessLast step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine
Significance: Feedback control of cholesterol metabolism is essential for cell viability and prevention of heart attacks. Cells acquire cholesterol from receptor-mediated uptake of low-density lipoprotein, which delivers cholesterol to lysosomes. To exert feedback control, cholesterol must reach the endoplasmic reticulum (ER). Here we use a CRISPR screen to show that lysosome-derived cholesterol moves first to the plasma membrane and then to the ER. The last movement requires an enzyme that produces phosphatidylserine. This demonstrates that transmembrane movement of one lipid (cholesterol) requires another lipid (phosphatidylserine). Our results explain how one organelle (ER) monitors the cholesterol content of another organelle (plasma membrane), thereby maintaining membrane integrity and ensuring cell survival.
- Open Access
- 26 July 2018
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 7
Lysosomal cholesterol export reconstituted from fragments of Niemann-Pick C1
Niemann-Pick C1 (NPC1) is a polytopic membrane protein with 13 transmembrane helices that exports LDL-derived cholesterol from lysosomes by carrying it through the 80 Å glycocalyx and the 40 Å lipid bilayer. Transport begins when cholesterol binds to the N-terminal domain (NTD) of NPC1, which projects to the surface of the glycocalyx. Here, we reconstitute cholesterol transport by expressing the NTD as a fragment separate from the remaining portion of NPC1. When co-expressed, the two NPC1 fragments reconstitute cholesterol transport, indicating that the NTD has the flexibility to interact with the remaining parts of NPC1 even when not covalently linked. We also show that cholesterol can be transferred from the NTD of one full-length NPC1 to another NPC1 molecule that lacks the NTD. These data support the hypothesis that cholesterol is transported through interactions between two or more NPC1 molecules.
- 26 July 2018
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 7
Open AccessLysosomal cholesterol export reconstituted from fragments of Niemann-Pick C1
Niemann-Pick C1 (NPC1) is a polytopic membrane protein with 13 transmembrane helices that exports LDL-derived cholesterol from lysosomes by carrying it through the 80 Å glycocalyx and the 40 Å lipid bilayer. Transport begins when cholesterol binds to the N-terminal domain (NTD) of NPC1, which projects to the surface of the glycocalyx. Here, we reconstitute cholesterol transport by expressing the NTD as a fragment separate from the remaining portion of NPC1. When co-expressed, the two NPC1 fragments reconstitute cholesterol transport, indicating that the NTD has the flexibility to interact with the remaining parts of NPC1 even when not covalently linked. We also show that cholesterol can be transferred from the NTD of one full-length NPC1 to another NPC1 molecule that lacks the NTD. These data support the hypothesis that cholesterol is transported through interactions between two or more NPC1 molecules.
- 1 February 2018
- Published by Elsevier in Carbohydrate Research
- Vol. 456, 24-29
Conjugation of carbohydrates to proteins using di(triethylene glycol monomethyl ether) squaric acid ester revisited
- 1 February 2018
- Published by Elsevier in Carbohydrate Research
- Vol. 456, 24-29
Conjugation of carbohydrates to proteins using di(triethylene glycol monomethyl ether) squaric acid ester revisited
- 7 August 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (34) , 9116-9121
3.3 Å structure of Niemann–Pick C1 protein reveals insights into the function of the C-terminal luminal domain in cholesterol transport
Significance: The Niemann–Pick C1 (NPC1) protein is responsible for transporting LDL-derived cholesterol out of late endosomes. Mutations in NPC1 lead to the fatal Niemann–Pick Type C disease. We present here an improved structure of an NPC1 protein at 3.3 Å and decipher details of its C-terminal luminal domain (CTD), which could not be resolved in previous structures. In particular, a loop stabilized by a pair of disulfide bonds in the CTD binds to the N-terminal domain through a loop–loop interaction. We show that this interaction is important for cholesterol transport in cultured cells. Together, our data provide insights related to the molecular mechanism of NPC1 activity and Niemann–Pick Type C disease.
- 7 August 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (34) , 9116-9121
3.3 Å structure of Niemann–Pick C1 protein reveals insights into the function of the C-terminal luminal domain in cholesterol transport
Significance: The Niemann–Pick C1 (NPC1) protein is responsible for transporting LDL-derived cholesterol out of late endosomes. Mutations in NPC1 lead to the fatal Niemann–Pick Type C disease. We present here an improved structure of an NPC1 protein at 3.3 Å and decipher details of its C-terminal luminal domain (CTD), which could not be resolved in previous structures. In particular, a loop stabilized by a pair of disulfide bonds in the CTD binds to the N-terminal domain through a loop–loop interaction. We show that this interaction is important for cholesterol transport in cultured cells. Together, our data provide insights related to the molecular mechanism of NPC1 activity and Niemann–Pick Type C disease.
- 19 December 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (1) , 89-94
Triazoles inhibit cholesterol export from lysosomes by binding to NPC1
Niemann–Pick C1 (NPC1), a membrane protein of lysosomes, is required for the export of cholesterol derived from receptor-mediated endocytosis of LDL. Lysosomal cholesterol export is reportedly inhibited by itraconazole, a triazole that is used as an antifungal drug [Xu et al. (2010) Proc Natl Acad Sci USA 107:4764–4769]. Here we show that posaconazole, another triazole, also blocks cholesterol export from lysosomes. We prepared P-X, a photoactivatable cross-linking derivative of posaconazole. P-X cross-linked to NPC1 when added to intact cells. Cross-linking was inhibited by itraconazole but not by ketoconazole, an imidazole that does not block cholesterol export. Cross-linking of P-X was also blocked by U18666A, a compound that has been shown to bind to NPC1 and inhibit cholesterol export. P-X also cross-linked to purified NPC1 that was incorporated into lipid bilayer nanodiscs. In this in vitro system, cross-linking of P-X was inhibited by itraconazole, but not by U18666A. P-X cross-linking was not prevented by deletion of the N-terminal domain of NPC1, which contains the initial binding site for cholesterol. In contrast, P-X cross-linking was reduced when NPC1 contained a point mutation (P691S) in its putative sterol-sensing domain. We hypothesize that the sterol-sensing domain has a binding site that can accommodate structurally different ligands.
- 19 December 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (1) , 89-94
Triazoles inhibit cholesterol export from lysosomes by binding to NPC1
Niemann–Pick C1 (NPC1), a membrane protein of lysosomes, is required for the export of cholesterol derived from receptor-mediated endocytosis of LDL. Lysosomal cholesterol export is reportedly inhibited by itraconazole, a triazole that is used as an antifungal drug [Xu et al. (2010) Proc Natl Acad Sci USA 107:4764–4769]. Here we show that posaconazole, another triazole, also blocks cholesterol export from lysosomes. We prepared P-X, a photoactivatable cross-linking derivative of posaconazole. P-X cross-linked to NPC1 when added to intact cells. Cross-linking was inhibited by itraconazole but not by ketoconazole, an imidazole that does not block cholesterol export. Cross-linking of P-X was also blocked by U18666A, a compound that has been shown to bind to NPC1 and inhibit cholesterol export. P-X also cross-linked to purified NPC1 that was incorporated into lipid bilayer nanodiscs. In this in vitro system, cross-linking of P-X was inhibited by itraconazole, but not by U18666A. P-X cross-linking was not prevented by deletion of the N-terminal domain of NPC1, which contains the initial binding site for cholesterol. In contrast, P-X cross-linking was reduced when NPC1 contained a point mutation (P691S) in its putative sterol-sensing domain. We hypothesize that the sterol-sensing domain has a binding site that can accommodate structurally different ligands.
- 1 September 2016
- Published by American Scientific Publishers in Journal of Nanoscience and Nanotechnology
- Vol. 16 (9) , 9063-9071
Chemically Powered Nanomotor as a Delivery Vehicle for Biologically Relevant Payloads
- 1 September 2016
- Published by American Scientific Publishers in Journal of Nanoscience and Nanotechnology
- Vol. 16 (9) , 9063-9071
Chemically Powered Nanomotor as a Delivery Vehicle for Biologically Relevant Payloads